Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » PCR » SpeeDx Launching Line of Multiplex STI, Microbial Resistance Assays

SpeeDx Launching Line of Multiplex STI, Microbial Resistance Assays

Oct 07, 2015
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – Australian molecular diagnostics manufacturer SpeeDx is developing a line of PCR-based in vitro diagnostics called PlexPCR using the firm's proprietary single-well multiplexing technologies. The initial tests are for certain sexually transmitted infections, and include one that can detect SNPs conferring antimicrobial resistance.

The firm has been "in technology development mode for five years," Colin Denver, vice president for sales and marketing at SpeeDx, told GenomeWeb in an interview.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Not Quite There Yet

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

Call for Open Science

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Accolades for a New University

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

Nucleic Acids Research Papers on IndiGenomes, DockCoV2, ViruSurf Databases

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.

Nov
05
Featured Webinar

Beyond Traditional Biopsy for Esophageal Cancer: Novel Sampling Methods to Improve Patient Care

Sponsored by
Roche

This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

Nov
11
Featured Webinar

Leveraging Genomics to Accelerate Genetic Improvement in Aquaculture

Sponsored by
Illumina

Selective breeding represents an efficient approach to increase production of aquaculture species by means of improving traits, such as rapid growth, product quality, and disease resistance.

Nov
17
Featured Webinar

Spatial Expression Analyses Elucidates Mechanisms of circRNAs in Cancer

Sponsored by
ACD

Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as), have been proposed to function as competitive endogenous RNAs (ceRNAs) by “sponging” specific microRNAs.

What's Popular?

In PCR

  1. Biodesix Prices $72M IPO

  2. Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test

  3. Qiagen Reports 26 Percent Q3 Revenue Growth; Ups Full-Year Guidance

  4. Moving From Reagents Supplier to Test Developer, Meridian Bio Expands Role During COVID-19 Pandemic

    Premium

  5. FDA Reissues EUA for Broad Institute Coronavirus Test, Authorizes Immunoassay From Celltrion

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.